GALNT12
Polypeptide N-acetylgalactosaminyltransferase 12
You are using an outdated browser. Please upgrade your browser to improve your experience.
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
gene perturbation | 0.87 | ||
PubMedID | 0.75 | ||
histone modification site profile | 0.73 | ||
transcription factor perturbation | 0.68 | ||
tissue sample | 0.67 | ||
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
- OR - satisfy the following criterion:
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Target has at least one approved drug - AND - satisfies the preceding conditions
Click on a row in the table to change the structure displayed.
Data Source | Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|---|
Reactome | Defective GALNT12 causes colorectal cancer 1 (CRCS1) | ||||
Reactome | Disease | ||||
Reactome | Diseases associated with O-glycosylation of proteins | ||||
Reactome | Diseases of glycosylation | ||||
Reactome | Metabolism of proteins | ||||
Name | Explore in Pharos | Explore in Source | ||
---|---|---|---|---|
Defective GALNT12 causes colorectal cancer 1 (CRCS1) | ||||
Disease | ||||
Diseases associated with O-glycosylation of proteins | ||||
Diseases of glycosylation | ||||
Metabolism of proteins | ||||
GO Term | Evidence | Assigned by | ||
---|---|---|---|---|
Traceable Author Statement (TAS) | Reactome | |||
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
Inferred from Electronic Annotation (IEA) | UniProtKB-KW | |||
GWAS Trait | EFO ID | Study Count | SNP Count | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|---|---|
body mass index | 1 | 1 | 1 | 17.8 | |||||
FEV/FEC ratio | 1 | 1 | 1 | 11.6 | |||||
1 | 1 | 0 | 1.1 | 9 | |||||
serum galactose-deficient IgA1 measurement | 1 | 1 | 1 | 4.3 | |||||
1 | 1 | 0 | 1.1 | 0.5 | |||||
GWAS Trait | EFO ID | Beta Count | Odds Ratio | Evidence (Mean Rank Score) | Provenance | ||
---|---|---|---|---|---|---|---|
body mass index | 1 | 17.8 | |||||
FEV/FEC ratio | 1 | 11.6 | |||||
0 | 1.1 | 9 | |||||
serum galactose-deficient IgA1 measurement | 1 | 4.3 | |||||
0 | 1.1 | 0.5 | |||||
Species | Name | Source ID | Gene ID | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|---|---|
Chimp | polypeptide N-acetylgalactosaminyltransferase 12 | VGNC:13882 | 747531 | |||||
Macaque | polypeptide N-acetylgalactosaminyltransferase 12 | 715128 | ||||||
Mouse | MGI:2444664 | 230145 | ||||||
Rat | RGD:1562001 | 313233 | ||||||
Dog | polypeptide N-acetylgalactosaminyltransferase 12 | VGNC:41087 | 474777 | |||||
Species | Name | OMA | EggNOG | Inparanoid | ||
---|---|---|---|---|---|---|
Chimp | polypeptide N-acetylgalactosaminyltransferase 12 | |||||
Macaque | polypeptide N-acetylgalactosaminyltransferase 12 | |||||
Mouse | ||||||
Rat | ||||||
Dog | polypeptide N-acetylgalactosaminyltransferase 12 | |||||
PMID | Year | Title |
---|